Brokers name 3 ASX shares to buy today

Here's why brokers are feeling bullish about these three shares this week.

| More on:
a group of people stand examining a large glowing cystral ball held in the hands of one of the group members while the others regard it with various expressions of wonder, curiousity and scepticism.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

It has been another busy week for many of Australia's top brokers. This has led to the release of a number of broker notes.

Three broker buy ratings that you might want to know more about are summarised below. Here's why brokers think these ASX shares are in the buy zone right now:

CSL Ltd (ASX: CSL)

According to a note out of Goldman Sachs, its analysts have initiated coverage on this biotechnology giant's shares with a buy rating and $325.40 price target. Goldman Sachs is feeling very positive about CSL's outlook and is forecasting double-digit immunoglobulin (IG) growth each year through to FY 2028. It expects this to be underpinned by low penetration and ~100 basis points year on year market share gains. Another positive is that Goldman highlights that its channel checks indicate that CSL's competitive advantages are intact, with the expansion in fractionation capacity set to enhance CSL's superior cost profile and supply reliability. This is expected to lead to margin expansion and strong earnings growth in the coming years. The CSL share price is trading at $276.86 on Friday.

NextDC Ltd (ASX: NXT)

A note out of Morgans reveals that its analysts have retained their add rating on this data centre operator's shares with a slightly trimmed price target of $20.00. Morgans has been updating its financial model ahead of earnings season. After factoring in its recent capital raising, the broker has trimmed its price target. However, it remains very positive on the company and its outlook. Morgans continues to believe that NextDC is well-placed to benefit from the structural growth in demand for data centres. The NextDC share price is fetching $15.58 at the time of writing.

ResMed Inc. (ASX: RMD)

Another note out of Goldman Sachs reveals that its analysts have initiated coverage on this sleep disorder treatment company's shares with a buy rating and $48.90. According to the note, the broker believes that ResMed is well-positioned to achieve the top end of is FY 2030 revenue financial target. This implies a compound annual growth rate of 8.9% between FY 2025 and FY 2030. It expects this to be underpinned by robust Continuous Airway Pressure Therapy (CPAP) patient growth, assisted by growing awareness on Obstructive Sleep Apnoea (OSA), market share gains, particularly in OSA masks, and operating margin expansion driven by product mix and solid cost management. The ResMed share price is trading at $38.24 on Friday morning.

Motley Fool contributor James Mickleboro has positions in CSL, Nextdc, and ResMed. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended CSL, Goldman Sachs Group, and ResMed. The Motley Fool Australia has positions in and has recommended ResMed. The Motley Fool Australia has recommended CSL. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

Two smiling work colleagues discuss an investment or business plan at their office.
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

A young man pointing up looking amazed, indicating a surging share price movement for an ASX company
Broker Notes

These ASX 200 shares could rise 30% to 40%

Analysts are tipping these shares to generate big returns over the next 12 months.

Read more »

A female worker in a hard hat smiles in an oil field.
Broker Notes

Buy BHP and this ASX 200 share next week

Here are a couple of shares that Bell Potter rate highly this month.

Read more »

A young man sits at his desk working on his laptop with a big smile on his face due to his ASX shares going up and in particular the Computershare share price
Broker Notes

Brokers name 3 ASX shares to buy today

Here's why brokers are feeling bullish about these three shares this week.

Read more »

A man slumps crankily over his morning coffee as it pours with rain outside.
Broker Notes

Why did this $1 billion ASX 300 stock just crash 10%?

This stock isn't having a good finish to the week. What's going on?

Read more »

A male sharemarket analyst sits at his desk looking intently at his laptop with two other monitors next to him showing stock price movements
Blue Chip Shares

Is it too late to buy this $33 billion ASX 200 stock?

Do analysts think this popular stock can deliver good returns for investors? Let's find out.

Read more »

a man sits at his desk wearing a business shirt and tie and has a hearty laugh at something on his mobile phone.
Broker Notes

5 ASX All Ords shares upgraded to 'strong buy' consensus ratings

Brokers upgraded their ratings on these ASX All Ords stocks last month.

Read more »

A couple cheers as they sit on their lounge looking at their laptop and reading about the rising Redbubble share price
Broker Notes

2 more of the best ASX 200 shares to buy in February

The broker is feeling very bullish about these shares. Let's see what it is saying.

Read more »